Kai Yin

1.5k total citations
54 papers, 1.1k citations indexed

About

Kai Yin is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Kai Yin has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Cancer Research and 18 papers in Surgery. Recurrent topics in Kai Yin's work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Kai Yin is often cited by papers focused on MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Kai Yin collaborates with scholars based in China, United States and France. Kai Yin's co-authors include Xusheng Chang, Mingming Nie, Yichen Wang, Dianwen Ju, Jingyun Luan, Jiajun Fan, Liheng Zhou, Wenjin Yin, Jinsong Lu and Jinghui Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Kai Yin

50 papers receiving 1.0k citations

Peers

Kai Yin

ONCOL

SURGE

IMMUN

Qingjian Ou China

Nobuyuki Nishizawa Japan

Melissa Swinnen Belgium

Qian Liang China

Charlotte E. Edling United Kingdom

Kaori Koga Japan

Masayuki Tanahashi Japan

Woon Yong Jung South Korea

Hao‐Chen Wang Taiwan

Martine Charbonneau Canada

Qingjian Ou China

Kai Yin

575 ×1.1

306 ×0.7

258 ×1.1

ONCOL

84 ×0.4

SURGE

120 ×0.7

IMMUN

Citations per year, relative to Kai Yin Kai Yin (= 1×) peers Qingjian Ou

Countries citing papers authored by Kai Yin

Since Specialization

Citations

This map shows the geographic impact of Kai Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Yin more than expected).

Fields of papers citing papers by Kai Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Yin. The network helps show where Kai Yin may publish in the future.

Co-authorship network of co-authors of Kai Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Yin. A scholar is included among the top collaborators of Kai Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Yin. Kai Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yin, Kai, Lu Ding, Xueyan Li, et al.. (2025). Causal role of plasma liposome in diabetic retinopathy: mendelian randomization (MR) study. Diabetology & Metabolic Syndrome. 17(1). 47–47.

Wang, Longfei, et al.. (2025). Targeting asparagine potentiates anti-PD-L1 immunotherapy in gastric cancer by enhancing CD8+ T cell anti-tumor response. Frontiers in Immunology. 16. 1626581–1626581.

Wang, Qiannan, et al.. (2024). Vessel invasion is a risk factor for gastric cancer: a retrospective analysis study. World Journal of Surgical Oncology. 22(1). 348–348.

Huang, Jiaojiao, et al.. (2023). Targeting STING in cancer: Challenges and emerging opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(6). 188983–188983. 29 indexed citations

Chen, Huiying, Na Ta, Zheng Shi, et al.. (2023). Anti-CD47 Antibody Enhances the Efficacy of Chemotherapy in Patients with Gastric Cancer Liver Metastasis. Journal of Cancer. 14(3). 350–359. 9 indexed citations

Pang, Tao, Mingming Nie, & Kai Yin. (2023). The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma. World Journal of Surgical Oncology. 21(1). 316–316. 1 indexed citations

Chang, Xusheng, Yuan Gao, Huan Han, et al.. (2022). Clinical significance of chromosomal integrity in gastric cancers. The International Journal of Biological Markers. 37(3). 296–305. 3 indexed citations

Dang, Sheng-Chun, Abdul Malik, Jixiang Chen, et al.. (2020). <p>LncRNA SNHG15 Contributes to Immuno-Escape of Gastric Cancer Through Targeting miR141/PD-L1</p>. OncoTargets and Therapy. Volume 13. 8547–8556. 37 indexed citations

Pang, Tao, Xiaoyi Yin, Tianhang Luo, et al.. (2019). Cancer‐associated fibroblasts promote malignancy of gastric cancer cells via Nodal signalling. Cell Biochemistry and Function. 38(1). 4–11. 9 indexed citations

10.

Xia, Yiwen, Linjun Wang, Zhipeng Xu, et al.. (2019). Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2‐Robo1 signalling on cell migration and EMT. Cell Proliferation. 52(3). e12606–e12606. 39 indexed citations

11.

Zhang, Xuyao, Yichen Wang, Jiajun Fan, et al.. (2019). Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 7(1). 346–346. 82 indexed citations

12.

Cai, Hui, Changqing Jing, Xusheng Chang, et al.. (2019). Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. Journal of Translational Medicine. 17(1). 189–189. 75 indexed citations

13.

Zhou, Kun, et al.. (2019). Crystallization kinetics of evaporation rubidium chloride in the MSMPR crystallizer. Revue Roumaine de Chimie. 64(3). 265–270. 1 indexed citations

14.

Du, Yueyao, Liheng Zhou, Yanping Lin, et al.. (2019). Polymorphisms in microRNA let-7 binding sites of the HIF1AN and CLDN12 genes can predict pathologic complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer. Annals of Translational Medicine. 7(7). 138–138. 8 indexed citations

15.

Du, Shangce, Kai Yin, Shichao Ai, et al.. (2018). Knockdown long noncoding RNA nuclear paraspeckle assembly transcript 1 suppresses colorectal cancer through modulating miR‐193a‐3p/KRAS. Cancer Medicine. 8(1). 261–275. 25 indexed citations

16.

Liu, Gan, Luting Zhou, Hai Zhang, et al.. (2017). Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20. Nature Communications. 8(1). 14824–14824. 54 indexed citations

17.

Su, Nan, Jiangtao Lin, Kai Yin, et al.. (2016). [A cross-section study of severe asthma in eight provinces of China].. PubMed. 55(12). 917–921. 8 indexed citations

18.

Zhang, Bin, Bin Song, Xin Wang, et al.. (2015). The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma. Tumor Biology. 36(7). 5459–5466. 51 indexed citations

19.

Liu, Xingzhen, et al.. (2014). Long-Term outcomes and experience of laparoscopic adjustable gastric banding: one center’s results in China. Surgery for Obesity and Related Diseases. 11(4). 855–859. 7 indexed citations

20.

Wang, Xiaowei, et al.. (2013). Laparoscopic adjustable gastric banding: a report of 228 cases. Gastroenterology report. 1(2). 144–148. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact